bullous pemphigoid

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bullous Pemphigoid Trial in Bhubaneswar (Prednisolone, Dapsone, Methotrexate)

Not yet recruiting
  • Bullous Pemphigoid
  • Bhubaneswar, Odisha, India
    AIIMS Bhubaneswar
Aug 9, 2023

Bullous Pemphigoid Trial (dupilumab)

Temporarily not available
  • Bullous Pemphigoid
  • (no location specified)
Jun 7, 2023

Bullous Pemphigoid Trial in Worldwide (dupilumab, Matching Placebo, Oral corticosteroids (OCS))

Recruiting
  • Bullous Pemphigoid
  • Scottsdale, Arizona
  • +50 more
Jan 13, 2023

Bullous Pemphigoid Trial (efgartigimod PH20 SC, Prednisone)

Not yet recruiting
  • Bullous Pemphigoid
  • (no location specified)
Dec 27, 2022

Dupilumab in Patients With Bullous Pemphigoid

Recruiting
  • Bullous Pemphigoid
  • Beijing, Beijing, China
    Peking University First Hospital
Dec 13, 2022

Bullous Pemphigoid Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Bullous Pemphigoid
  • Benralizumab
  • Placebo
  • Phoenix, Arizona
  • +66 more
Nov 18, 2022

Pemphigus Vulgaris, Bullous Pemphigoid Trial in Cairo (Ozonated olive oil, Topical garamycin cream)

Recruiting
  • Pemphigus Vulgaris
  • Bullous Pemphigoid
  • Ozonated olive oil
  • Topical garamycin cream
  • Cairo, Egypt
    Dermatology Department, Cairo University Hospitals
Nov 4, 2022

Bullous Pemphigoid Trial in Worldwide (nomacopan (rVA576), Placebo)

Withdrawn
  • Bullous Pemphigoid
  • nomacopan (rVA576)
  • Placebo
  • Los Angeles, California
  • +11 more
Oct 18, 2022

Bullous Pemphigoid Trial in Worldwide (biological, other, drug)

Recruiting
  • Bullous Pemphigoid
  • efgartigimod PH20 SC
  • +2 more
  • Fountain Valley, California
  • +24 more
Jul 27, 2022

Telederm and Bullous Pemphigoid

Recruiting
  • Bullous Pemphigoid
    • Atlanta, Georgia
      Emory Dermatology Clinic
    Jun 3, 2022

    Simplified Severity Score in Bullous Pemphigoid

    Not yet recruiting
    • Bullous Pemphigoid
    • IGA score
    • BULLOUS PEMPHIGOID DISEASE AREA INDEX (BPDAI)
    • Bordeaux, France
    • +10 more
    May 4, 2022

    Human Leukocyte Antigen Class II Alleles and Haplotypes

    Recruiting
    • Pemphigus
    • +3 more
    • A single blood sample for HLA typing
    • Moscow, Russian Federation
      Sechenov University
    Mar 10, 2022

    Bullous Pemphigoid Trial in Reims (Ustekinumab)

    Recruiting
    • Bullous Pemphigoid
    • Reims, France
      Damien JOLLY
    Mar 15, 2022

    Bullous Pemphigoid Trial in Nice, Marseille, Montpellier (Avdoralimab (IPH5401), Control)

    Recruiting
    • Bullous Pemphigoid
    • Avdoralimab (IPH5401)
    • Control
    • Nice, Alpes-Maritimes, France
    • +3 more
    Feb 18, 2022

    Pemphigus Vulgaris, Pemphigus Foliaceus, Bullous Pemphigoid Trial in Philadelphia (Questionnaires)

    Recruiting
    • Pemphigus Vulgaris
    • +2 more
    • Questionnaires
    • Philadelphia, Pennsylvania
    • +2 more
    Jan 29, 2022

    Bullous Pemphigoid Trial in Montpellier (clobetasol propionate + Methotrexate, clobetasol propionate alone)

    Completed
    • Bullous Pemphigoid
    • clobetasol propionate + Methotrexate
    • clobetasol propionate alone
    • Montpellier, France
      University Hospital Of Montpellier
    Jan 24, 2022

    Bullous Pemphigoid Trial in Germany, Italy (DF2156A)

    Terminated
    • Bullous Pemphigoid
    • Freiburg, Germany
    • +3 more
    Jan 14, 2022

    Bullous Pemphigoid Trial in Sacramento (Rituximab combined with Omalizumab)

    Not yet recruiting
    • Bullous Pemphigoid
    • Rituximab combined with Omalizumab
    • Sacramento, California
      University of California, Davis, Department of Dermatology
    Aug 16, 2021

    Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy

    Unknown status
    • Bullous Pemphigoid
    • +2 more
    • Not concerned
    • Nantes, France
      University Hospital
    Nov 18, 2020

    Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors

    Active, not recruiting
    • Bullous Pemphigoid
      • Athens, Attiki, Greece
        "Attikon" University General Hospital
      Sep 21, 2020

      Bullous Pemphigoid, Pemphigoid Trial in Scottsdale (Ixekizumab)

      Completed
      • Bullous Pemphigoid
      • Pemphigoid
      • Scottsdale, Arizona
        Mayo Clinic
      May 11, 2020

      Bullous Pemphigoid Trial in Taipei (AC-203 1% Topical Ointment, Clobetasol 0.05% Topical Ointment)

      Terminated
      • Bullous Pemphigoid
      • AC-203 1% Topical Ointment
      • Clobetasol 0.05% Topical Ointment
      • Taipei, Taiwan
        National Taiwan University Hospital
      Sep 17, 2019

      Osteoporosis, Bullous Pemphigoid Trial (bone densitometry, blood test, radiographs of the thoracic and lumbar spine)

      Unknown status
      • Osteoporosis
      • Bullous Pemphigoid
      • bone densitometry
      • +3 more
      • (no location specified)
      Apr 23, 2019

      Pruritus and Evaluation of Quality of Life in Bullous Pemphigoid

      Completed
      • Bullous Pemphigoid
        • Argenteuil, France
        • +15 more
        Jan 4, 2019

        Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development

        Unknown status
        • Bullous Pemphigoid
        • data report
        • Marseille, Paca, France
          Assistance Publique Des Hopitaux de Marseille
        Aug 16, 2018